Contact
Please use this form to send email to PR contact of this press release:
FDA Clears First-in-Indication Cell Therapy Trial for Chronic Traumatic Encephalopathy — for the Warriors Who Carry CTE
TO:
Kathryn Dziedzic
TriCelX
+1 970-305-1165